Want to see IN:UNICHEMLAB full AI Analyst Report?

Unichem Laboratories Limited (UNICHEMLAB) Price & Analysis

0 Followers

UNICHEMLAB Stock Chart & Stats

₹443.05

-₹12.85(-1.76%)

At close: Jan 08 4:00 PM EST

₹443.05

-₹12.85(-1.76%)

Day’s Range― - ―

52-Week Range₹280.00 - ₹656.85

Previous CloseN/A

Volume14.19K

Average Volume (3M)1.03K

Market Cap

₹33.32B

Enterprise Value₹33.70B

Total Cash (Recent Filing)₹1.94B

Total Debt (Recent Filing)₹5.02B

Price to Earnings (P/E)13.0

Beta1.41

Next Earnings

Aug 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)12.56

Shares Outstanding70,405,754

10 Day Avg. Volume1,013

30 Day Avg. Volume1,033

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)0.76

Price to Sales (P/S)0.94

P/FCF Ratio-14.89

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthLow, stable leverage and rising equity provide resilience across business cycles, giving Unichem capacity to fund working capital, absorb shocks, or support strategic investments without immediate reliance on volatile cash flow. This structural strength underpins longer-term solvency and strategic optionality.

Diversified Branded Portfolio & MarketsA multi-therapy branded formulation franchise across domestic and export markets reduces single-product and single-market concentration risk. This structural diversification supports stable revenue pools, cross-market commercialization, and the ability to reallocate commercial effort if demand shifts, enhancing medium-term revenue resilience.

Return To ProfitabilityThe company’s recovery from recent loss years to positive net margins indicates tangible operational or commercial improvements. If sustained, this shift can translate into normalized earnings power and a foundation for rebuilding cash generation, improving credit metrics and supporting reinvestment or shareholder returns over the coming months.

Bears Say

Weak Cash GenerationPersistent negative operating cash flow and consistently negative free cash flow mean reported earnings are not converting into cash. This structural cash shortfall forces reliance on external financing or asset sales, raises execution risk if funding tightens, and limits genuine capacity for capex or dividends over the medium term.

Thin Operating MarginsA low operating margin leaves the business exposed to input cost inflation, pricing pressure, or reimbursement changes. Coupled with volatile gross margins, this structural vulnerability reduces earnings predictability and increases the likelihood that modest adverse moves will erode profitability and impede sustained cash flow improvement.

Revenue Growth DecelerationA reversal from multi-year growth to a revenue contraction signals emerging demand, competitive, or execution pressures. If the slowdown persists, it could reverse the recent profit recovery and exacerbate cash burn, increasing the company's dependence on its balance sheet strength or external funding over the medium term.

Unichem Laboratories Limited News

Unichem Labs Files FY 2026 Business Responsibility and Sustainability Report

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has issued an update. Unichem Laboratories has submitted its Business Responsibility and...

2d ago

Unichem Sets August 11 AGM to Ratify Accounts, Extend CEO Tenure and Cost Audit Mandate

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an announcement. Unichem Laboratories Limited has scheduled its 63rd Annual...

2d ago

Unichem Publishes FY26 Results in Newspapers, Notifies Exchanges

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an update. Unichem Laboratories has notified stock exchanges that its...

1M ago

Unichem’s U.S. Unit Voluntarily Recalls Buspirone Tablets on Quality Deviation

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) just unveiled an announcement. Unichem Pharmaceuticals (USA), Inc., the U.S. arm of...

3M ago

Unichem Shareholders Clear Director Appointment and Key Related-Party Deals via Postal Ballot

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an announcement. Unichem Laboratories has announced the results of a...

3M ago

Unichem Laboratories Settles European Commission Fine

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an update. Unichem Laboratories Limited has announced the payment of...

8M ago

Unichem Laboratories Faces Demand Notice from NPPA for Alleged Overcharging

The latest update is out from Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ). Unichem Laboratories Limited has received a...

9M ago

Unichem Laboratories Receives USFDA Inspection Report

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) just unveiled an announcement. Unichem Laboratories Limited announced that it has received...

10M ago

UNICHEMLAB FAQ

What was Unichem Laboratories Limited’s price range in the past 12 months?

Unichem Laboratories Limited lowest stock price was ₹280.00 and its highest was ₹656.85 in the past 12 months.

What is Unichem Laboratories Limited’s market cap?

Unichem Laboratories Limited’s market cap is ₹33.32B.

When is Unichem Laboratories Limited’s upcoming earnings report date?

Unichem Laboratories Limited’s upcoming earnings report date is Aug 12, 2026 which is in 38 days.

How were Unichem Laboratories Limited’s earnings last quarter?

Unichem Laboratories Limited released its earnings results on May 22, 2026. The company reported ₹1.55 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.55.

Is Unichem Laboratories Limited overvalued?

According to Wall Street analysts Unichem Laboratories Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Unichem Laboratories Limited pay dividends?

Unichem Laboratories Limited pays a Annually dividend of ₹4 which represents an annual dividend yield of N/A. See more information on Unichem Laboratories Limited dividends here

What is Unichem Laboratories Limited’s EPS estimate?

Unichem Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Unichem Laboratories Limited have?

Unichem Laboratories Limited has 70,405,754 shares outstanding.

What happened to Unichem Laboratories Limited’s price movement after its last earnings report?

Unichem Laboratories Limited reported an EPS of ₹1.55 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.799%.

Which hedge fund is a major shareholder of Unichem Laboratories Limited?

Currently, no hedge funds are holding shares in IN:UNICHEMLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Unichem Laboratories Limited

Unichem Laboratories Limited is an international pharmaceutical company engaged in the development, manufacturing, and commercialization of a wide array of medicinal products. The firm's portfolio features finished pharmaceutical formulations designed to treat numerous health conditions, including those related to gastroenterology, cardiovascular health, diabetes, mental health, neurological disorders, bacterial and other infectious diseases, and pain relief. Beyond these formulations, Unichem also provides active pharmaceutical ingredients (APIs) and offers contract manufacturing solutions. This enterprise was established in 1944 and operates from its corporate headquarters in Mumbai, India.